G Glenmark Apri29, 2016 ‘The Dy. General Manager Dept. of corporate Afars The Bombay Stock Exchange Ltd, Phiroze leeleebhoy Towers Dalal street ‘Mumba: 400008, \We are enclosing herewith a press release informing “lenmark Pharmaceutials receives tentative ANDA approval for Adapalene and Benzoy Peroxide Gel, 0.1% 2.5%" for your Information an record Thanking you Yours fitful, For Glenmark Pharmaceuticals id ‘sanjay Kumar Chowdhary ‘Company Secretary & Compliance Officer Tet 4018 9999 / 4018 9879 Fx No: 4018 9886 (Legal & Secretarial Dept) Encl: as aboveGS glenmai Forimmodiae Release Glenmark Pharmaceuticals receives tentative ANDA approvel for, ‘Adapalene and Benzoyl Peroxide Gel, 0.1%|2.5% ia; April 28,2016: Glenmark Pharmaceuticals Inc, USA (Glenmark) has been granted ‘entatve approval by the Unltd States Food & Orug Adminisation (US. FDA) for Adapalene and Benzo! Peroxide Gel, 0.1%12.5% the gnerc version of Epidue® Galo Galderma Laboratories LP. ‘According to MS Heath sles data forthe 12 month petod ending February 2016, te Epido® Gel market" achieved annual sales of approximately $351.8 milion* ‘Glenmark’ current portfolio consists of 112 protucts authored for strbution in the US. ‘marketlace and 58 ANDH's pending approval wih the U.S. FO. In addon to these interal ings, ‘Glenmark continues to identfy and explore external development partnerships to applement and accelerate the growth ofits existing pipeline and portfolio. "at ices and and alse hcp cals Sh hea Natrol Persea Ret & Nao Ret eb 2036 2kSG Glenmark ‘About lenmark Pharmaceuticals kd. Glenmark Pharmaceuticals Lid. (GPL) Ie a reearcheven, global, Integrated pharmaceutical organization headquartered at Mumbai, India. is ranked among the top BD Phirms & Biotech companies ofthe world in texms of revenue (SCHP 100 Renkings published inthe year 2026), “Glenmark sa leading player inthe discovery of new molecules bath NCES new chemical entity] and INBES (now biological entity), Glenmark has several molecules in various stages of clinical “development and is primary focused in the areas of inflammation [asthma/COPO, rheumatoid artnet} and Pain neuropathic pln an iaiammatory pala ‘he company has siglcant presence in the branded generis markets across emeiing economies Inclaing nd. GPL along with its subsidiary has 16 manufacturing acts across fe counties and has sc RAD centers, The Generics business of Glenmark services the requirement of the US and Western European markets. The APL business sels prosucts in aver 80 counties, including the US, various countriesin the EU, South America and ni For further information, lease contact: Rarskumar Uppara/Shibani Shah Glenmart, Mumba, nd +91 22) 2026 s984/S34 mall: compconmddlenmarksharma com